Genetic variants in toll-like receptors are not associated with rheumatoid arthritis susceptibility or anti-tumour necrosis factor treatment outcome.
Coenen MJ, Enevold C, Barrera P, Schijvenaars MM, Toonen EJ, Scheffer H, Padyukov L, Kastbom A, Klareskog L, Barton A, Kievit W, Rood MJ, Jansen TL, Swinkels D, van Riel PL, Franke B, Bendtzen K, Radstake TR.
Coenen MJ, et al. Among authors: scheffer h.
PLoS One. 2010 Dec 15;5(12):e14326. doi: 10.1371/journal.pone.0014326.
PLoS One. 2010.
PMID: 21179534
Free PMC article.